Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute myeloid leukemia: advancing clinical trials and promising therapeutics.

Expert review of hematology - 1 May 2016

Daver Naval, Cortes Jorge, Kantarjian Hagop, Ravandi Farhad

Abstract excerpt

Recent progress in understanding the biology of acute myeloid leukemia (AML) and the identification of targetable driver mutations, leukemia specific antigens and signal transduction pathways has ushered in a new era of therapy. In many circumstances the response rates with such targeted or antibody-based therapies are superior to those achieved with standard therapy and with decreased toxicity. In this review we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to fms-Like Tyrosine Kinase 3

Share to Isocitrate Dehydrogenase

Share to Molecular Targeted Therapy

Share to Remission Induction

Share to Salvage Therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 26910051
DOI: 10.1586/17474086.2016.1158096
PMCID: PMC5006674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute myeloid leukemia: advancing clinical trials and promising therapeutics.PMID 26910051Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Advances in acute myeloid leukemia.Semantic proximity Read ↗

Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.Semantic proximity Read ↗

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.Semantic proximity Read ↗

New agents for acute myeloid leukemia: is it time for targeted therapies?Semantic proximity Read ↗

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.Semantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

Recent advances in targeted therapies in acute myeloid leukemia.Semantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.